Eli Lilly Continues Migraine IP Wins Over Teva With PTAB Ax
Eli Lilly has persuaded the Patent Trial and Appeal Board to invalidate a Teva Pharmaceuticals patent for the migraine drug Ajovy, shortly after a Massachusetts federal judge overturned a related $176.5...To view the full article, register now.
Already a subscriber? Click here to view full article